Company News for March 16, 2010 - Corporate Summary
• UBS (NYSE:UBS) upgraded Starbucks (NASDAQ:SBUX) to "buy" from "neutral" with a $29 price target
• Goldman Sachs (NYSE:GS) upgraded Coventry Health Care (NYSE:CVH) to "neutral" and removed the shares from its Conviction Sell List, noting in-line valuation levels
• Piper Jaffray (NYSE:PJC) upgraded Sonic (NASDAQ:SONC) to "overweight" from "underweight," raising the price target to $12 from $8
• Goldman Sachs (NYSE:GS) upgraded Onyx Pharmaceuticals (NASDAQ:ONXX) to "buy" from "neutral," taking the price target to $37 from $34
• Citigroup (NYSE:C) upgraded Wal-Mart (NYSE:WMT) shares, with its price target raised to $65
• Goldman Sachs (NYSE:GS) moved Boston Scientific (NYSE:BSX) to its Conviction Sell List, downgrading the shares from "neutral" to "sell." Yesterday Boston Scientific shares fell 12.6% on news of its plans to pull certain defibrillator models from the market
• After the market closed, Limited Brands (NYSE:LTD) announced plans to pay a special dividend of $1 per share, as well as its approval of a new $200 million share buyback, which includes $31 million of the previous plan
• Discover (NYSE:DFS) is due to report fiscal first quarter earnings after the close today. Analysts expect the company to report a 12 cent profit, up from last year's 36 cent loss
The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
